RO4917838
Drug timelines are a Plus or Pro feature.
14 regulatory and trial events tracked for RO4917838, covering 2014-06-24 to 2017-06-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310) [Phase 3]